ABSTRACT
Fungal infection is one of the major health problems that frequently occur in the oral cavity. The consequences are exacerbated by a concomitant increase in resistance to traditional antifungal agents (Oberoi et al. 2012) due to the rise in the immunodeficient and immunocompromised populations globally. Among all causative agents, Candida albicans is the principal species and considered the most virulent. In this context, the identification of effective alternative therapies to the current antifungal agents is important.
